Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations
about
Primary Prevention of Stroke in Chronic Kidney Disease Patients: A Scientific Update.Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the "rubber effect".Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).Key topics in pulmonary vascular diseases (assembly 13) from the European Respiratory Society 2018 Parisian CongressDosing challenges with direct oral anticoagulants in the elderly: a retrospective analysisAppropriateness of DOAC Prescribing Before and During Hospital Admission and Analysis of Determinants for Inappropriate PrescribingChronic kidney disease can increase the risk of preoperative deep vein thrombosis in middle-aged and elderly patients with hip fractures
P2860
Q47188294-DC7DC9EC-DA58-48D9-8778-410BA9630522Q55089049-DBAF45A5-BCCE-4B4E-A2D4-9F8F62FC5067Q55476982-7C7B802E-CCDE-4511-89A2-52929066F7DBQ57494702-8BBD139B-BDAE-4F5F-8876-516107BE60E9Q58574436-29B80810-F7D4-441C-BE08-042953698C31Q58697853-AAECE5D5-5188-4831-99FA-0C37FBDFC0DBQ58751094-3C7B76B9-9FD4-4091-AF06-A3B15815B184
P2860
Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Direct oral anticoagulants in ...... ion and special considerations
@en
type
label
Direct oral anticoagulants in ...... ion and special considerations
@en
prefLabel
Direct oral anticoagulants in ...... ion and special considerations
@en
P2093
P2860
P356
P1476
Direct oral anticoagulants in ...... ion and special considerations
@en
P2093
Helmut Schinzel
Kerstin Jurk
P2860
P304
P356
10.2147/IJNRD.S105771
P407
P577
2017-06-12T00:00:00Z